Department of Dermatology

Engineering Therapeutic Regulatory T Cells to Overexpress G Protein-Coupled Receptor 15 Improves Functional Fitness for In Vivo Gut Homing (2025) Müller T, Liu L, Wiesinger M, Atreya I, Atreya R, Bacher P, Becker C, et al. Journal article, Letter NFATc1 in CD4+ T cells and CD11c+ dendritic cells drives TH2-mediated eosinophilic inflammation in allergic asthma (2025) Yang Z, Krammer S, Mitländer H, Grund J, Zirlik S, Wirtz S, Rauh M, et al. Journal article Discordance, accuracy and reproducibility study of pathologists' diagnosis of melanoma and melanocytic tumors (2025) Haggenmüller S, Wies C, Abels J, Winterstein JT, Heinlein L, Nogueira Garcia C, Utikal JS, et al. Journal article Loading of CAR‐T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism (2025) Pfister F, Carnell L, Löffler L, Boosz P, Schaft N, Dörrie J, Stein R, et al. Journal article Drug therapies for Ulcus cruris Medikamentöse Therapien des Ulcus cruris (2025) Ronicke M, Erfurt-Berge C Journal article Mastocytosis in the age of precision medicine: Position paper of the German Society of Allergy (AeDA) on the management of indolent systemic mastocytosis (2025) Siebenhaar F, Brehler R, Christen D, Hartmann K, Altrichter S, Joest M, aufm Kampe K, et al. Journal article Proteome Analysis of Corynebacterium diphtheriae–Macrophage Interaction (2025) Musella L, Möller J, Lischer C, Vera González J, Hofmann J, Ott L, Burkovski A Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status (2025) Placke JM, Rajcsanyi LS, Herbst R, Terheyden P, Utikal J, Pföhler C, Kreuter A, et al. Journal article